Screening for Arthrofibrosis after Anterior Cruciate Ligament Reconstruction: Analysis of Association with Human Leukocyte Antigen

Arthroscopy - Journal of Arthroscopic and Related Surgery

Volumn 20, Issue 5, 2004, Pages 469-473

  Skutek, Michael ^a   Elsner, Holger A ^a   Slateva, Kalina ^a   Mayr, Hermann O ^b   Weig, Thomas G ^b   Van Griensven, Martijn ^a   Krettek, Christian ^a   Bosch, Ulrich ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b SANA KLINIKUM OFFENBACH   (Germany)

Author keywords

ACL reconstruction; Arthrofibrosis; Genetic predisposition; HLA association

Indexed keywords

DNA; HLA ANTIGEN; HLA DQB1 ANTIGEN;

ADULT; ANTERIOR CRUCIATE LIGAMENT; ANTERIOR CRUCIATE LIGAMENT RUPTURE; ARTHROFIBROSIS; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; FEMALE; FIBROSIS; FOLLOW UP; GENETIC PREDISPOSITION; HLA SYSTEM; HLA TYPING; HUMAN; JOINT MOBILITY; JOINT STIFFNESS; KNEE LIGAMENT INJURY; KNEE MENISCUS RUPTURE; KNEE SURGERY; MALE; PHYSIOTHERAPY; POSTOPERATIVE CARE; RETROSPECTIVE STUDY; SCREENING TEST; TENDON TRANSPLANTATION; TREATMENT OUTCOME;

EID: 2442631599     PISSN: 07498063     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arthro.2004.03.003     Document Type: Article

References (26)

1. Harner CD, Irrgang JJ, Paul J, et al. Loss of motion after anterior cruciate ligament reconstruction. Am J Sports Med 1992;20:499-506.
2. Millett PJ, Wickiewicz TL, Warren RF. Motion loss after ligament injuries to the knee: Part I: causes. Am J Sports Med 2001;29:664-675.
3. Zeichen J, van Griensven M, Albers I, et al. Immunohistochemical localization of collagen VI in arthrofibrosis. Arch Orthop Traumatic Surg 1999;119:315-318.
4. Bosch U, Zeichen J, Lobenhoffer P, et al. Obersichtsarbeit: Ätiologie der Arthrofibrose. Arthroskopie 1999;12:215-221.
5. Bosch U, Zeichen J, Skutek M, et al. Arthrofibrosis is the result of a T cell mediated immune response. Knee Surg Sports Traumatol Arthrosc 2001;9:282-289.
6. Murakami S, Muneta T, Furuya K, et al. Immunohistologic analysis of synovium in infrapatellar fat pad after anterior cruciate ligament injury. Am J Sports Med 1995;23:763-768.
7. Skutek M, van Griensven M, Zeichen J, et al. Cyclic mechanical stretching modulates secretion pattern of growth factors in human tendon fibroblasts. Eur J Appl Physiol 2001;86:322-326.
8. Murakami S, Muneta T, Ezura Y, et al. Quantitative analysis of synovial fibrosis in the infrapatellar fat pad before and after anterior cruciate ligament reconstruction. Am J Sports Med 1997;25:29-34.
9. Ghellai AM, Stucci AF, Chegini N, et al. Role of transforming growth factor beta-1 in peritonitis-induced adhesions. J Gastrointest Surg 2000;4:316-323.
10. Tredget EE, Wang R, Shen Q, et al. Transforming growth factor-beta mRNA and protein in hypertrophic scar tissues and fibroblasts: Antagonism by IFN-alpha and IFN-gamma in vitro and in vivo. J Interferon Cytokine Res 2000;20:143-151.
11. Krotzsch-Gomez FE, Furuzawa-Carballeda J, Reyes-Marquez R, et al. Cytokine expression is downregulated by collagen-polyvinylpyrrolidone in hypertrophic scars. J Invest Dermatol 1998;111:828-834.
12. Marshall RP, McAnulty RJ, Laurent GJ. The pathogenesis of pulmonary fibrosis: Is there a fibrosis gene? Int J Biochem Cell Biol 1997;29:107-120.
13. Briggs DC, Vaughan RW, Welsh KI, et al. Immunogenetic prediction of pulmonary fibrosis in systemic sclerosis. Lancet 1991;338:661-662.
14. Hawkins BR, Dawkins RL, Christiansen Fr, Zilko PJ. Use of the B27 test in the diagnosis of ankylosing spondylitis: A statistical evaluation. Arthritis Rheum 1981;24:743-746.
15. Shelbourne KD, Patel DV, Martini DJ. Classification and management of arthrofibrosis of the knee after anterior cruciate ligament reconstruction. Am J Sports Med 1996;24:857-862.
16. Blasczyk R, Hahn U, Wehling J, et al. A complete subtyping of the HLA-A locus by sequence-specific amplification followed by direct sequencing or single strand conformation polymorphism analysis. Tissue Antigens 1995;46:86-95.
17. Slateva K, Albis-Camps M, Blasczyk R. Fluorotyping of HLA-A by sequence-specific priming and fluorogenic probing. Tissue Antigens 1998;52:462-472.
18. Bunce M, O'Neill CM, Barnado MCNM. Comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 and DQB1 by PCR with 144 primers mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995;46:355-367.
19. Lenhard V, Peters A, Ballas M. Caucasian German normal. In: Gjertson DW, Terasaki PI, eds. HLA 1998. Lenexa, KS: American Society for Histocompatibility and Immunogenetics, 1998;146-147.
20. Schwartz K, Woelpl A, Spegel J, et al. Caucasian German normal. In: Gjertson DW, Teresaki PI, eds. HLA 1998. Lenexa, KS: American Society for Histocompatibility and Immunogenetics, 1998;149.
21. Kuhröber A, Knipper AJ, Enczmann J, et al. Caucasian German normal. In: Gjertson DW, Terasaki PI, eds. HLA 1998. Lenexa, KS: American Society for Histocompatibility and Immunogenetics, 1998;148.
22. Svejgaard A, Ryder RP. HLA and disease associations: Detecting the strongest association. Tissue Antigens 1994;43:18-27.
23. Arnett KL, Huang W, Valiante NM, et al. The Bw4/Bw6 difference between HLA-B*0802 and B*0801 changes the peptides endogenously bound and the stimulation of alloreactive T cells. Immunogenetics 1998;48:56-61.
24. Hill AV, Elvin J, Willis AC, et al. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 1992;360:434-439.
25. Cella M, Longo A, Ferrara GB, et al. NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J Exp Med 1994;180:1235-1242.
26. Gumperz JE, Barber LD, Valiante NM, et al. Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell inhibitory receptor. J Immunol 1997; 158:5237-5241.